Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Dec 21, 2021Advances company's innovation focus on enabling new care settings and accelerating smart connected care
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of privately held Scanwell Health Inc., a leader in...
-
Dec 17, 2021BD COR™ MX for Infectious Disease Testing Receives CE Mark and is Final Instrument Introduced on BD COR™ System
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has expanded the BD COR™ System to include a new MX instrument for high-throughput...
-
Dec 15, 2021€70 Million Investment to Establish New Research Laboratories, Jobs in Software Engineering, Informatics and Cybersecurity
LIMERICK, IRELAND (15TH Dec. 2021) –BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to create more than 130 new jobs and invest €
-
Dec 9, 2021
Stamford, Conn. – Dec. 9, 2021 – The global medical technology company, BD (Becton, Dickinson and Company), has committed $500,000 to improve quality of care and reduce health inequities for...
-
Dec 9, 2021- Acquisition complements BD's core portfolio - adding an innovative, broadly applicable surgical sealant to a suite of BD biosurgery products already relied upon in the operating room.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England...
-
Dec 8, 2021Addition of 100 local jobs will play key role in bolstering manufacturing capacity to supply the market with pre-filled flush syringes for use in health care settings
DROGHEDA, IRELAND (December 8, 2021) – BD (Becton Dickinson and Company), a leading global medical technology company, held a ribbon cutting ceremony today to announce the creation of 100 new...
-
Dec 6, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that "embecta" [pronounced em-BECK-tah] will be the name of the independent,...
-
Dec 2, 2021- Acquisition marks BD's entry point to the treatment of Chronic Venous Insufficiency -- adding transformative solutions to its existing venous disease portfolio with the potential to reshape patient care.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic...
-
Dec 1, 2021Progress Builds Strong Foundation for Bold 2030+ ESG Goals to Advance the World of Health for All
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the release of its 2021 Global Inclusion, Diversity and Equity (ID&E) Report. The...
-
Nov 30, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding testing for the COVID-19 Omicron variant of concern....
-
Nov 29, 2021Digital Health Pioneer to Focus on External Innovation; Becomes Co-Chair of BD Scientific Advisory Board
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Joseph M. Smith has been named senior vice president and chief scientific...
-
Nov 24, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced Francesca DeMartino has been named senior vice president of investor relations for the...
-
Nov 16, 2021New facility will expand BD’s capacity to supply the European market with pre-fillable syringes for use in applications such as vaccines and other biologic drugs; add 150 local jobs by 2024.
FRANKLIN LAKES, N.J. (November 16, 2021) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, broke ground on a €165 million ($200 million USD)...
-
Nov 12, 2021- Innovation agenda focuses on advancing human health through smart connected care, new care settings and chronic disease outcomes
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will begin its Investor Day at 8 a.m. ET today to share how it plans to leverage the breadth and depth...
-
Nov 4, 2021- Fourth fiscal quarter revenues of $5.1 billion grew 7.3% on a reported basis or 5.9% on a currency-neutral basis.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for the fourth fiscal quarter and full fiscal year ended September 30, 2021....
-
Nov 4, 2021
The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.87 per common share, an increase of 4.8% from the previous quarter. The dividend...
-
Oct 28, 2021BARDA to Invest $24.7 Million for BD to Develop New Tests for Core Labs, Hospitals and Point-of-Care Locations
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the formation of a strategic, public-private partnership with the Biomedical Advanced...
-
Oct 26, 2021Event will provide strategic update, with focus on company's innovation and growth agendas
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a virtual investor day on Friday, Nov. 12, 2021 at 8 a.m., which will...
-
Oct 26, 2021- BD Veritor™ At-Home COVID-19 Test is now available for purchase on Amazon.com
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has started to ship the first over-the-counter (OTC) COVID-19 rapid antigen test to...
-
Oct 22, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Carrie L. Byington has been appointed to the company's board of directors,...
-
Oct 18, 2021Building on More Than Two Decades of Achievements, BD Making Bold ESG Commitments to Advance the World of Health for All
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new strategy to advance environmental, social and governance (ESG) initiatives, as...
-
Oct 13, 2021
New product is intended to support biologic drugs with high viscosity formulations*, complex design space requirements and support the delivery of medications for chronic diseases FRANKLIN LAKES,...
-
Oct 7, 2021New Manufacturing Lines Will Provide U.S. Government with Priority Access to Hundreds of Millions of Needles and Syringes; Bolster Supply Readiness
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has strengthened the U.S. government's access to safety injection devices through...
-
Oct 6, 2021Rotarex™ Rotational Excisional Atherectomy System is the first and only atherectomy and thrombectomy device indicated to treat in-stent restenosis in the United States
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance for expanded indications from the U.S. Food and Drug...
-
Oct 4, 2021
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will report its fiscal 2021 fourth quarter and full year financial results on Thursday, Nov. 4, 2021. BD will issue a press...